Evidence map›Paper›PMID 28302721›Full record

ArticleThe Journal of biological chemistry2017

Involvement of Notch1 signaling in malignant progression of A549 cells subjected to prolonged cadmium exposure.

Kota Fujiki, Hisako Inamura, Takamitsu Miyayama, Masato Matsuoka

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Mechanisms of Heavy Metal Cadmium (Cd)-Induced Malignancy.Biological trace element research · 2025
    Review
  3. Article
  4. Review
  5. Notch signaling, hypoxia, and cancer.Frontiers in oncology · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Consecutive Hypoxia Decreases Expression ofFrontiers in cell and developmental biology · 2020
    Article
  17. Article
  18. Cadmium induces A549 cell migration and invasion by activating ERK.Experimental and therapeutic medicine · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kota FujikiFrom the Department of Hygiene and Public Health I, Tokyo Women's Medical University, Tokyo 162-8666, Japan bunnsidairoku@gmail.com.
Hisako InamuraFrom the Department of Hygiene and Public Health I, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Takamitsu MiyayamaFrom the Department of Hygiene and Public Health I, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Masato MatsuokaFrom the Department of Hygiene and Public Health I, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Tokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cadmium exposure is known to increase lung cancer risk, but the underlying molecular mechanisms in cadmium-stimulated progression of malignancy are unclear. Here, we examined the effects of prolonged cadmium exposure on the malignant progression of A549 human lung adenocarcinoma cells and the roles of Notch1, hypoxia-inducible factor 1α (HIF-1α), and insulin-like growth factor 1 receptor (IGF-1R)/Akt/extracellular signal-regulated kinase (ERK)/p70 S6 kinase 1 (S6K1) signaling pathways. Exposing A549 cells to 10 or 20 μm cadmium chloride (CdCl

Indexed as

Signal TransductionA549 CellsAntigens, CDAntineoplastic AgentsBronchiCadherinsCadmium ChlorideCarcinoma, Non-Small-Cell LungDisease ProgressionEpithelial CellsEpithelial-Mesenchymal TransitionExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitLung NeoplasmsAKT1 protein, humanAntigens, CDAntineoplastic AgentsCadherinsCadmium ChlorideCDH1 protein, humanExtracellular Signal-Regulated MAP KinasesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIGF1R protein, humanNOTCH1 protein, humanProto-Oncogene Proteins c-aktReceptor, IGF Type 1Receptor, Notch1Receptors, Somatomedinribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaRNA, Small Interferingcadmiumdrug resistanceepithelial-mesenchymal transition (EMT)lung cancermetalNotch pathway

Identifiers

PMID28302721
PMCPMC5427272
OpenAlexW2596106469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.